Radient Technologies Inc. (RDDTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 13, 2025
Radient Technologies Revenue
Radient Technologies had revenue of 1.03M CAD in the quarter ending December 31, 2022, a decrease of -34.73%. This brings the company's revenue in the last twelve months to 3.15M, down -20.41% year-over-year. In the fiscal year ending March 31, 2022, Radient Technologies had annual revenue of 3.62M with 45.49% growth.
Revenue (ttm)
3.15M CAD
Revenue Growth
-20.41%
P/S Ratio
0.84
Revenue / Employee
95.40K CAD
Employees
33
Market Cap
1.96M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2022 | 3.62M | 1.13M | 45.49% |
Mar 31, 2021 | 2.49M | -15.92M | -86.47% |
Mar 31, 2020 | 18.40M | 18.19M | 8,497.83% |
Mar 31, 2019 | 214.06K | -241.77K | -53.04% |
Mar 31, 2018 | 455.83K | 162.38K | 55.34% |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Mar 31, 2014 | Pro | Pro | Pro |
Mar 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Radient Technologies News
- 2 years ago - Radient Technologies Announces Board Changes - Newsfile Corp
- 2 years ago - Radient Announces Update on Trading Reinstatement - Newsfile Corp
- 2 years ago - Radient Announces Revocation of Failure-to-File Cease Trade Order - Newsfile Corp
- 2 years ago - Radient Technologies Inc. Provides Status Update Regarding Its Interim Financial Statements - Newsfile Corp
- 2 years ago - Radient Announces Anticipated Issuance of Failure-to-File Cease Trade Order - Newsfile Corp
- 2 years ago - Radient Announces Potential Delay in Filing Interim Financials - Newsfile Corp
- 2 years ago - Radient Appoints Interim CEO, Appoints Director, and Announces Financing - Newsfile Corp
- 2 years ago - Radient Provides an Update on Annual Financial Statements Filing - Newsfile Corp